alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 6,601–6,625 of 7,816 matching trials · page 265 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation
NCT02149160
FRM-0334; Placebo
Runs in: Belgium; France; Italy; Netherlands; United Kingdom; Unit... · 13 sites 		PHASE2
other		 UNKNOWN 30 FORUM Pharmaceuticals Inc
INDUSTRY		 2016-03-23
Omental Transposition Surgery for Mild Alzheimer's Disease
NCT02349191
Omental transposition for mild Alzheimers disease 		NA
other		 UNKNOWN 25 Bariatric Medicine Institute, Salt Lake City, UT
OTHER		 2016-03-22
Postoperative Cognitive Decline, Inflammation, and Plasma Levels of Beta-amyloids
NCT00850928
Runs in: United States · 1 site 		NA
other		 COMPLETED 41 NYU Langone Health
OTHER		 2016-03-17
Effects of Light-therapy in Alzheimer's Disease
NCT02686190
Luxtherapy
Runs in: France · 1 site 		NA
other		 COMPLETED 91 Assistance Publique - Hôpitaux de Paris
OTHER		 2016-03-17
The Montreal Cognitive Assessment as a Screening Tool for Preoperative Mild Cognitive Impairment in Geriatric Patients
NCT01496222
Runs in: Thailand · 1 site 		NA
other		 UNKNOWN 582 Mahidol University
OTHER		 2016-03-16
Impact of tDCS on Cerebral Autoregulation
NCT01865604
Anodal tDCS; Cathodal tDCS; sham tDCS
Runs in: Germany · 1 site 		NA
other		 COMPLETED 60 Charite University, Berlin, Germany
OTHER		 2016-03-16
Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
NCT01266525
SAR110894; placebo (for SAR110894); Donepezil
Runs in: Australia; Canada; France; Germany; Italy; Poland; Portug... · 82 sites 		PHASE2
symptomatic-cholinergic		 COMPLETED 291 Sanofi
INDUSTRY		 2016-03-14
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
NCT00712426
Creatine Monohydrate; Placebo
Runs in: Australia; Canada; New Zealand; United States · 47 sites 		PHASE3
other		 TERMINATED 553 Massachusetts General Hospital
OTHER		 2016-03-11
Alzheimer's Disease Multiple Intervention Trial
NCT01314950
Home based occupational therapy; Best practices primary care
Runs in: United States · 1 site 		NA
other		 COMPLETED 180 Indiana University
OTHER		 2016-03-08
Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-999 in Healthy Young Male Volunteers
NCT02208934
PBF-999; Placebo
Runs in: Spain · 2 sites 		PHASE1
other		 COMPLETED 32 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
OTHER		 2016-03-08
Memory Problems Perceptions Among Patients and Accompaniers During Diagnosis Process :
NCT02299154
Psychological questionnaires
Runs in: France · 1 site 		NA
other		 UNKNOWN 250 Central Hospital, Nancy, France
OTHER		 2016-03-08
Retina Microvascular Remodeling and Cognitive Function In Hypertension
NCT02701855
Cognitive tests; Blood test; Brain and aorta RMI; Adaptative optics
Runs in: France · 1 site 		NA
other		 UNKNOWN 160 Institute of Cardiometabolism and Nutrition, France
OTHER		 2016-03-08
Cognitive Behavioral Aggression Treatment
NCT01264900
Psychotherapy
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 120 Temple University
OTHER		 2016-03-04
Body Temperature in Persons With Tetraplegia When Exposed to Cold
NCT01822535
Midodrine hydrochloride
Runs in: United States · 1 site 		PHASE4
other		 COMPLETED 30 James J. Peters Veterans Affairs Medical Center
OTHER_GOV		 2016-03-04
Enhancing Cognitive and Neurobehavioral Functions After Repetitive Traumatic Brain Injuries (rTBI) in Retired NFL Players and Military Veterans.
NCT02699476
Psycho-Social Therapy; Cognitive Behavioral Computer Training; Inte...
Runs in: United States · 1 site 		NA
other		 UNKNOWN 60 Brain & Body Health Foundation
OTHER		 2016-03-04
A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease
NCT01320527
Nutriceutical formulation; Placebo
Runs in: United States · 8 sites 		PHASE2
other		 COMPLETED 135 University of Massachusetts, Worcester
OTHER		 2016-03-03
Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease
NCT01227564
ACC-001 3 μg/ QS-21 50 μg; ACC-001 10 μg/ QS-21 50 μg; Placebo- Pho...
Runs in: United States · 40 sites 		PHASE2
other		 COMPLETED 63 Pfizer
INDUSTRY		 2016-02-25
Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells(UC-MSC) in Patients With Alzheimer's Disease
NCT01547689
Human Umbilical Cord Derived MSC
Runs in: China · 1 site 		PHASE1|PHASE2
other		 UNKNOWN 30 Affiliated Hospital to Academy of Military Medical Sciences
OTHER		 2016-02-22
Early Counseling and Support for Alzheimer's Disease Caregivers
NCT02685787
Psychosocial Intervention; Educational Intervention on AD
Runs in: Italy · 1 site 		NA
other		 UNKNOWN 230 Azienda Sanitaria Locale N.1 dell'Umbria
OTHER		 2016-02-19
Honolulu Heart Program-Study of Stroke and Dementia
NCT00005395 		NA
other		 COMPLETED — National Heart, Lung, and Blood Institute (NHLBI)
NIH		 2016-02-18
Complementary Interventions on Patients With Dementia: Comparative and Longitudinal Research
NCT02126059
Reminiscence; Cognitive stimulation; Aroma-massage
Runs in: Taiwan · 1 site 		NA
other		 COMPLETED 120 National Cheng-Kung University Hospital
OTHER		 2016-02-17
Dose Response Study of Aerobic Exercise in Older Adults
NCT01129115
Nonexercise control group; Aerobic Exercise Group 1; Aerobic Exerci...
Runs in: United States · 1 site 		EARLY_PHASE1
other		 COMPLETED 101 Jeff Burns, MD
OTHER		 2016-02-15
24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion
NCT02361242
PXT00864
Runs in: France · 1 site 		PHASE2
other		 COMPLETED 45 Pharnext S.C.A.
OTHER		 2016-02-15
Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD)
NCT02361424
PXT00864; placebo
Runs in: France · 1 site 		PHASE2
other		 COMPLETED 47 Pharnext S.C.A.
OTHER		 2016-02-15
Bexarotene Amyloid Treatment for Alzheimer's Disease
NCT01782742
Bexarotene; Placebo
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 20 The Cleveland Clinic
OTHER		 2016-02-12

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →